Clinical policies aim to prevent avoidable harm to patients by only offering treatments on the NHS that are evidence-based, clinically safe and effective, as well as cost effective and a good use of resources.
Currently there is not a single clinical policy for transcranial magnetic stimulation (TMS and rTMS) that applies to people across the whole Central East area.
Where a legacy Integrated Care Board (ICB) had an agreed clinical policy on transcranial magnetic stimulation (TMS and rTMS), this policy transferred to Central East ICB on 1 April 2026. Previously agreed policies will continue to apply only to people living in that former ICB’s area until any new policy is adopted by NHS Central East ICB.
Where an area doesn’t have a previously agreed policy on transcranial magnetic stimulation (TMS and rTMS), support for patients in that area will be based on a routine commissioning pathway.
Local clinical policy positions for transcranial magnetic stimulation (TMS and rTMS)
Bedfordshire, Luton and Milton Keynes
No Policy (Routine Commissioning Pathway)
Cambridgeshire and Peterborough
Hertfordshire and West Essex
Transcranial Magnetic Stimulation (TMS and rTMS) v1.0 Jul 2022 (256kB pdf)